Dec 09, 2022

Letter of Hope from Theresa Werner, Senior Director of Clinical Research

This time of year, many people think about their families and loved ones. For those who know someone with cancer, the season can be overwhelming. In this latest Letter of Hope, Theresa Werner, MD, describes how clinical trials are trying to ease that burden and provide hope for patients now and in the future.

Sep 28, 2022

Speaking Out for Ovarian and Gynecologic Cancer Awareness Month

After being diagnosed and treated for ovarian cancer, obstetrician Janice Byrne was determined to make a difference for others facing the same disease. Now, she advocates to increase education and awareness about ovarian cancer and provide support to newly diagnosed patients.

Sep 16, 2022

Love, Friends, and Faith: Two-Time Cancer Patient Shares Her Story

When Jeanette Nielsen was diagnosed with multiple myeloma, she turned to the professional care teams and clinical trials at Huntsman Cancer Institute. "We knew that clinical trials in the past made treatments possible for the present, which I benefited from. Now I want to pay it forward so future patients can benefit as well."

Sep 12, 2022

Letter of Hope from Sach Apte, Gynecologic Oncologist

Sachin Apte, MD, chief clinical officer at Huntsman Cancer Institute and physician-in-chief of the cancer hospital, shares a Letter of Hope with patients. He details his decision to become an gynecologic oncologist and its impact on him.

Jul 26, 2022

Frequent Aspirin Use Shows Promise for Preventing Ovarian Cancer in Individuals at Higher Risk

A new Huntsman Cancer Institute study published in the Journal of Clinical Oncology shows frequent aspirin use is linked with lower ovarian cancer risk in people with multiple risk factors. Britton Trabert, PhD, MS, investigator in the Cancer Control and Population Sciences Program explains her research, how she hopes it improves potential preventive measures, and what lies ahead.

Jun 06, 2022

Recognizing Research Excellence: Suneja, Hu-Lieskovan, and Sborov Named Translational Scholars

New members added to The Society of Huntsman Translational Scholars. They include Gita Suneja, MD, MS; Siwen Hu-Lieskovan, MD, PhD; and Douglas Sborov, MD, MS.

Jun 03, 2022

5 For The Fight Announces New Class of Cancer Research Fellows

5 For The Fight, a nonprofit started by Qualtrics and fueled by thousands of private donors, announced today that seven new cancer researchers will get a boost for their work thanks to $1.1 million in grants. Five women and two men, who are part of the multi-year 5 For The Fight Cancer Research Fellows program, were vetted and chosen in part for their pledge to focus on cancer research.

Jan 24, 2022

Ask an Expert: Cervical Cancer

Cervical cancer was once the leading cause of cancer deaths for women in the United States. Now, thanks to the development of early screening techniques, that’s no longer the case. Yet every year, there are still around 13,800 new cases of cervical cancer. To learn more about cervical cancer prevention, diagnosis, and treatment, we spoke with Kate Harris, MD, a gynecologic oncologist.